Clinical study abbreviated report. A Phase III, randomized, open-label, comparative study of caelyx versus paclitaxel HCI in patients with epithelial ovarian carcinoma following failure of first-line, platinum-based chemotherapy, protocol 30-57

Authors
Category Primary study
Year 2004
This article has no abstract
Epistemonikos ID: 22a1dc5b24ee62b6faeaee648ba7244c2edd27bc
First added on: May 29, 2020